Skip to main content

Table 2 Traditional meta-analysis results of optimal transplantation dose

From: The optimal transplantation strategy of umbilical cord mesenchymal stem cells in spinal cord injury: a systematic review and network meta-analysis based on animal studies

Group

Dose

The third week (SMD)

The fifth week (SMD)

Local transplantation + acute phase transplantation

High dose

2.93 (0.90, 4.96)

6.38 (2.96, 9.81)

Low dose

2.22 (1.23, 3.22)

2.83 (1.56, 4.11)

Local transplantation + subacute phase transplantation

High dose

2.92 (1.80, 4.05)

5.42 (3.36, 7.47)

Low dose

1.49 (0.48, 2.51)

2.56 (0.82, 4.31)

Intravenous transplantation + acute phase transplantation

High dose

2.57 (0.90, 6.03)

4.63 (2.83, 6.43)

Low dose

1.60 (0.91, 2.29)

1.80 (0.30, 3.30)